Showing results (61-70 of 351) with videos related to
Sort By:
Pageof 36
American Journal of Respiratory and Critical Care Medicine|January 26, 2023
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best PracticeBartolome R Celli, Leonardo M Fabbri, Shawn D Aaron, et al.Deutsches Arzteblatt International|October 5, 2018
Medical Treatment of COPDJana Graf, Rudolf A Jörres, Tanja Lucke, et al.Respiratory Medicine|September 27, 2017
GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational studyHeinrich Worth, Roland Buhl, Carl-Peter Criée, et al.International Journal of Chronic Obstructive Pulmonary Disease|August 11, 2017
Perception of symptoms and quality of life - comparison of patients' and physicians' views in the COPD MIRROR studyBartolome Celli, Francesco Blasi, Mina Gaga, et al.Respiratory Medicine|January 29, 2013
A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPDEdward M Kerwin, Catherine Scott-Wilson, Lisa Sanford, et al.American Journal of Respiratory and Critical Care Medicine|May 8, 2026
A GOLD Science Committee Perspective on Exacerbations and Cardiovascular Risk In COPDDave Singh, Alvar Agustí, Jean Bourbeau, et al.International Journal of Chronic Obstructive Pulmonary Disease|September 30, 2021
Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims DataAlisa Stöber, Johanna I Lutter, Larissa Schwarzkopf, et al.ERJ Open Research|March 1, 2021
Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trialsDavid M G Halpin, Claus F Vogelmeier, Karen Mezzi, et al.International Journal of Cardiology|October 12, 2015
Wall stress determines systolic and diastolic function--Characteristics of heart failurePeter Alter, A Rembert Koczulla, Christoph Nell, et al.Expert Review of Respiratory Medicine|May 8, 2014
Recent advances in COPD disease management with fixed-dose long-acting combination therapiesEric D Bateman, Donald A Mahler, Claus F Vogelmeier, et al.Pageof 36